At a glance
ClinicalIndex Comparison RecordN/ACompleted· 7,057 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Time Limited Observational Study of the Moderately Preterm Infant (29 0/7 - 33 6/7 Weeks)
In Brief
An observational study for Infant, Newborn and Infant, Moderate Preterm. Completed, enrolled 7,057 participants across 19 sites.
Detailed Summary
This is a registry of moderate preterm infants, born alive at 29-33 weeks gestational age, in NICHD Neonatal Research Network (NRN) centers. The registry collects observational baseline data on both mothers and infants, and the therapies used and outcomes of the infants. The information collected is not specific to a disease or treatment (i.e., it is "generic"). Data are analyzed to find associations and trends between baseline information, treatments, and infant outcome, and to develop future NRN trials.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInfant, Newborn, Infant, Moderate Preterm
CountriesUnited States
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedFeb 2013
Primary CompletionOct 2013
Study CompletionFeb 2014
TodayJul 2026
First PostedFeb 15, 2013
Enrollment StartMar 1, 2012
Primary CompletionOct 1, 2013
Study CompletionFeb 1, 2014
TodayJul 1, 2026
Enrollment to primary: 1.6 yearsPosted 13.4 years ago